Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea
Clinical trial NCT04419259 · UNKNOWN
Trial details
- NCT number
- NCT04419259
- Sponsor
- Messoud Ashina
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.